Back to results
US 2014/0228307 A1Published application
Composition and method for treating an autoimmune disease
AssigneeRedHill Biopharma Ltd.
InventorsReza Fathi, Patrick Laughlin McLean, Harry Jefferson Leighton
Life of this patent
Estimating the term…
Abstract
A combination of antibiotics including rifabutin, clarithromycin and clofazimine for the treatment of an autoimmune disease such as multiple sclerosis and related diseases. In a further aspect, there is provided a composition comprising a combination of two or more antibiotic agents for the treatment of an autoimmune disease, said two or more antibiotic agents selected from rifabutin, clofazimine, and at least one macrolide.
Claims20
1-61. (canceled)
A composition comprising:
- an effective amount of rifabutin;
- an effective amount of clarithromycin;
- and
- an effective amount of clofazimine,
- wherein the effective amounts of rifabutin, clarithromycin, and clofazimine are sufficient to enable treatment of a subject suffering from an autoimmune disease by targeting cytokines or cytokine receptors.
2 more elements
Dependencies are inferred from the claim text.